130 related articles for article (PubMed ID: 7771472)
21. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
[TBL] [Abstract][Full Text] [Related]
22. Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes.
Castoldi G; Cuneo A
Baillieres Clin Haematol; 1996 Mar; 9(1):19-33. PubMed ID: 8730549
[TBL] [Abstract][Full Text] [Related]
23. Myelodysplasia or myeloneoplasia: thoughts on the nosology of clonal myeloid diseases.
Lichtman MA
Blood Cells Mol Dis; 2000 Dec; 26(6):572-81. PubMed ID: 11112390
[No Abstract] [Full Text] [Related]
24. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
Winfield DA; Polacarz SV
J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
[No Abstract] [Full Text] [Related]
25. Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group.
Barnard DR; Kalousek DK; Wiersma SR; Lange BJ; Benjamin DR; Arthur DC; Buckley JD; Kobrinsky N; Neudorf S; Sanders J; Miller LP; Shina DC; Hammond GD; Woods WG
Leukemia; 1996 Jan; 10(1):5-12. PubMed ID: 8558938
[TBL] [Abstract][Full Text] [Related]
26. Identification and quantitation of blasts in myeloid malignancies with marrow fibrosis or marrow hypoplasia and CD34 negativity.
Nedumannil R; Sim S; Westerman D; Juneja S
Pathology; 2021 Oct; 53(6):795-798. PubMed ID: 33612271
[No Abstract] [Full Text] [Related]
27. Variable persistence of leukemic progenitor cells in long-term CML and AML marrow cultures.
Coulombel L; Eaves CJ; Dubé ID; Kalousek DK; Eaves AC
Kroc Found Ser; 1984; 18():243-54. PubMed ID: 6597867
[No Abstract] [Full Text] [Related]
28. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
[TBL] [Abstract][Full Text] [Related]
29. Secondary myelodysplastic syndromes following peripheral blood stem cell transplantation: morphological, cytogenetic and clonality evaluation and the limitation of FAB criteria.
Laurenti L; d'Onofrio G; Sica S; Chiusolo P; Zini G; Piccirillo N; Zollino M; Garzia M; Sora F; Leone G
Bone Marrow Transplant; 2000 Jul; 26(2):241-2. PubMed ID: 10918441
[No Abstract] [Full Text] [Related]
30. Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?).
Bennett JM; Tuechler H; Aul C; Strupp C; Germing U
Leuk Res; 2016 Aug; 47():63-9. PubMed ID: 27258735
[TBL] [Abstract][Full Text] [Related]
31. Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes.
Goasguen JE; Bennett JM; Bain BJ; Brunning R; Vallespi MT; Tomonaga M; Zini G; Renault A;
Leuk Res; 2014 Apr; 38(4):447-53. PubMed ID: 24439566
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate and bone marrow metaphases.
Cunningham JJ; Potter AM; Watmore AE; Winfield DA
Cancer Genet Cytogenet; 1988 Jul; 33(2):213-24. PubMed ID: 3164245
[TBL] [Abstract][Full Text] [Related]
33. Significance of bone marrow sideroblastosis in myelodysplastic syndromes.
Economopoulos T; Karakassis D; Stathakis N; Pappa V; Raptis S
Eur J Haematol; 1990 Aug; 45(2):118-20. PubMed ID: 2209817
[No Abstract] [Full Text] [Related]
34. Dysgranulopoiesis, low blast count and t(8;21): an unusual presentation of t(8;21) AML according to the WHO classification: a pediatric experience.
Latger-Cannard V; Buisine J; Fenneteau O; Accard F; Duchayne E; Lagrange M; Bayle C
Leuk Res; 2001 Nov; 25(11):1023-4. PubMed ID: 11597738
[No Abstract] [Full Text] [Related]
35. Histological study of bone marrow regeneration following chemotherapy for acute myeloid leukaemia and chronic granulocytic leukaemia in blast transformation.
Islam A; Catovsky D; Galton DA
Br J Haematol; 1980 Aug; 45(4):535-40. PubMed ID: 7000152
[No Abstract] [Full Text] [Related]
36. [Myelocytic leukemia and its classification].
Maekawa T; Umegae S
Nihon Rinsho; 1981 Aug; 39(8):2733-40. PubMed ID: 7038197
[No Abstract] [Full Text] [Related]
37. [Myelodysplastic syndromes--from FAB to WHO classification].
Kotlarek-Haus S; Haus O
Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
[No Abstract] [Full Text] [Related]
38. Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome.
Eridani S; Chan LC; Halil O; Pearson TC
Br J Haematol; 1985 Nov; 61(3):525-9. PubMed ID: 3864486
[TBL] [Abstract][Full Text] [Related]
39. Myelodysplastic syndromes: a study of 101 cases according to the FAB classification.
Vallespi T; Torrabadella M; Julia A; Irriguible D; Jaen A; Acebedo G; Triginer J
Br J Haematol; 1985 Sep; 61(1):83-92. PubMed ID: 3863667
[TBL] [Abstract][Full Text] [Related]
40. Morphologic classification of acute myeloid leukemia: concordance among Eastern Cooperative Oncology Group investigators: a comment.
Bennett JM; Cassileth PA; Paietta E; Rowe JM; Wiernik PH
Leukemia; 1996 Aug; 10(8):1365. PubMed ID: 8709645
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
